Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

PharmaJet® Needle-Free Flu Shots Offered in Workplace Health Clinics

Posted on: 04 Oct 16

PR Newswire

GOLDEN, Colo., Oct. 4, 2016

GOLDEN, Colo., Oct. 4, 2016 /PRNewswire/ -- Needle-free flu shots using the PharmaJet Injection System will be offered at workplace health clinics this flu season.  Denver International Airport, Cargill, Ernst & Young and Morgan Stanley are among the larger U.S. organizations offering employees flu shots with the PharmaJet needle-free device.

"We are excited to partner with organizations in their efforts to offer an alternative to needles for their employees to ensure a safe and healthy workplace.  Last year offering needle-free in workplace health clinics resulted in a double digit percentage increase in employees signing up to participate,1 and 93% said they would choose needle-free again for their next flu shot.2  Participants like the choice of a needle-free flu vaccination, and providers really like the technology," said Ron Lowy, Chairman and Chief Executive Officer of PharmaJet, Inc.

The PharmaJet Needle-Free Injection System is safe, fast and easy to administer.  Because it does not use any needles, it eliminates the possibility of needlestick injuries and provides individuals an alternative to receiving a flu vaccination reducing anxiety associated with needles.  For more information on PharmaJet's needle-free technology and how to schedule a needle-free flu clinic, please visit

Refer to Instructions for Use to ensure safe injections and to review risks.

1 PharmaJet, Inc. (2016) internal customer communications record
2 PharmaJet, Inc. (2015), "61-10233 Post Market Surveillance – Corporate Flu Clinics", internal company report, December 2015.

About PharmaJet
Based in Golden, Colorado, PharmaJet's mission is worldwide acceptance of PharmaJet needle-free devices as a standard of care in the vaccine delivery market.  PharmaJet's devices are also integral in the development of multiple novel pharmaceuticals.  The innovative Stratis® Injector has U.S. FDA 510(k) marketing clearance, CE Mark and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously.  In August 2014, the PharmaJet Stratis® Needle-free Injector was cleared for delivery of an influenza vaccine to deliver needle-free flu shots.  The PharmaJet Tropis® device for intradermal injections received authorization to apply the CE Mark in May 2016.  The PharmaJet Needle-free Injectors are safe, fast and easy-to-use.  They eliminate needlestick injuries, needle reuse and cross contamination, and help reduce sharps waste disposal.  For more information, visit

Jackie Daane


To view the original version on PR Newswire, visit:

SOURCE PharmaJet

PR Newswire

Last updated on: 04/10/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.